Bottle Label 30 mg (71610 0218 30)
Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 71610-218
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 71610-218). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena Pharma Solutions (TN)
Chemical Structure (Duloxetine 01)
Figure 1 (Duloxetine 02)
This is a graph that shows the proportion of patients who experienced relapse over time from randomization to relapse, in days, for two different treatments (placebo and duloxetine). The data is presented in percentages ranging from 0 to 10.*
Figure 2 (Duloxetine 03)
This is a graph showing the proportion of patients experiencing relapse over time from randomization to relapse (in days) for a treatment group receiving Duloxetine compared to a group receiving a placebo. The x-axis represents the number of days, and the y-axis represents the proportion of patients affected. The data is shown through five bars, with the highest proportion of relapse at day 10 for both groups, and the lowest proportion at day 250.*
Figure 3 (Duloxetine 04)
The text is describing a chart displaying the percentage of patients and their improvement in pain from baseline. The x-axis shows the percent improvement in pain from baseline while the y-axis displays the percent of patients improved. The chart shows that no patients were improved by 0%, 210 patients by 22%, 230 patients by 24%, and so on. The text also mentions some medication options, but it is not clear how they relate to the chart.*
Figure 4 (Duloxetine 05)
Figure 7 (Duloxetine 06)
This is a chart or graph showing the percentage of patients who experienced improvement in pain after being treated with a drug, compared to those who received a placebo. The drug being evaluated is likely named DUL, and was administered at a dose of 601120 mg once daily. The x-axis shows the degree of improvement in pain, ranging from 0% to 100%, while the y-axis displays the percentage of patients who experienced that level of improvement.*
Figure 8 (Duloxetine 07)
Figure 9 (Duloxetine 08)
The graph shows the percentage of patients improved in terms of pain from baseline using a placebo and DUL at 60/120 mg once daily. The x-axis represents the percent improvement in pain from baseline, while the y-axis represents the percentage of patients improved.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
